Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of Parkinson's disease pathophysiology using an integrated genomics-bioinformatics approach.

Pathophysiology : the official journal of the International Society for Pathophysiology·2014
Same author

The Differential Gene Expression Pattern of Mycobacterium tuberculosis in Response to Capreomycin and PA-824 versus First-Line TB Drugs Reveals Stress- and PE/PPE-Related Drug Targets.

International journal of microbiology·2009
Same author

Genome-wide analysis of intergenic regions of Mycobacterium tuberculosis H37Rv using Affymetrix GeneChips.

EURASIP journal on bioinformatics & systems biology·2008
Same author

The gene expression data of Mycobacterium tuberculosis based on Affymetrix gene chips provide insight into regulatory and hypothetical genes.

BMC microbiology·2007
Same author

Understanding the action of INH on a highly INH-resistant Mycobacterium tuberculosis strain using Genechips.

Tuberculosis (Edinburgh, Scotland)·2006
Same author

Genome-wide exploration of the drug action of capreomycin on Mycobacterium tuberculosis using Affymetrix oligonucleotide GeneChips.

The Journal of infection·2006
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
See all related articles

Related Experiment Video

Updated: Jan 26, 2026

Author Spotlight: Efficient Image Recognition Using Directional Gradient Histogram Technique and Support Vector Machines
08:27

Author Spotlight: Efficient Image Recognition Using Directional Gradient Histogram Technique and Support Vector Machines

Published on: January 5, 2024

1.6K

Machine learning and tubercular drug target recognition.

Li M Fu1

  • 1Research and Development, Veterans Affairs Healthcare System, 5901 E. 7th Street, Long Beach, CA 90822, USA. lifu@patcar.org.

Current Pharmaceutical Design
|November 20, 2013
PubMed
Summary
This summary is machine-generated.

Tuberculosis (TB) drug discovery faces challenges due to persistent Mycobacterium tuberculosis. Combining machine learning and genomics offers a promising approach to identify novel TB drug targets more effectively.

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.4K
Novel Object Recognition Test for the Investigation of Learning and Memory in Mice
08:52

Novel Object Recognition Test for the Investigation of Learning and Memory in Mice

Published on: August 30, 2017

77.3K

Related Experiment Videos

Last Updated: Jan 26, 2026

Author Spotlight: Efficient Image Recognition Using Directional Gradient Histogram Technique and Support Vector Machines
08:27

Author Spotlight: Efficient Image Recognition Using Directional Gradient Histogram Technique and Support Vector Machines

Published on: January 5, 2024

1.6K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.4K
Novel Object Recognition Test for the Investigation of Learning and Memory in Mice
08:52

Novel Object Recognition Test for the Investigation of Learning and Memory in Mice

Published on: August 30, 2017

77.3K

Area of Science:

  • Microbiology
  • Genomics
  • Computational Biology

Background:

  • Tuberculosis (TB) is a significant global health issue caused by Mycobacterium tuberculosis, which can persist in hosts post-treatment.
  • Mycobacterial persistence is a key challenge in developing new TB drugs.
  • Genomic technologies offer high-throughput screening for potential TB drug targets.

Purpose of the Study:

  • To review the integration of machine learning and genomics for tuberculosis drug discovery.
  • To explore how computational approaches can enhance the identification of effective TB drug targets.

Main Methods:

  • Reviewing the application of machine learning algorithms (pattern recognition, inductive learning) in TB research.
  • Analyzing genomic data for drug target identification properties like uniqueness, essentiality, and binding potential.

Main Results:

  • Genomic screening alone is not always productive for identifying TB drug targets.
  • Machine learning can refine the search process by formulating it as a pattern recognition problem.
  • Combining machine learning with genomics provides a powerful strategy for tuberculosis drug discovery.

Conclusions:

  • Integrating machine learning with genomics is a promising strategy to overcome challenges in tuberculosis drug discovery.
  • This combined approach can improve the efficiency and effectiveness of identifying novel drug targets against persistent Mycobacterium tuberculosis.
  • Further research in this interdisciplinary area is crucial for developing next-generation TB therapeutics.